Jane Street’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-204,500
| Closed | -$3.79M | – | 10058 |
|
|
2023
Q3 | $3.79M | Buy |
204,500
+146,800
| +254% | +$1.66M | ﹤0.01% | 3012 |
|
|
2023
Q2 | $638K | Sell |
57,700
-46,300
| -45% | -$645K | ﹤0.01% | 5943 |
|
|
2023
Q1 | $1.4M | Sell |
104,000
-136,100
| -57% | -$2.35M | ﹤0.01% | 4416 |
|
|
2022
Q4 | $2.97M | Sell |
240,100
-149,700
| -38% | -$2.12M | ﹤0.01% | 3246 |
|
|
2022
Q3 | $5.44M | Buy |
389,800
+225,600
| +137% | +$3.63M | ﹤0.01% | 2478 |
|
|
2022
Q2 | $2.27M | Buy |
164,200
+80,200
| +95% | +$1.28M | ﹤0.01% | 3929 |
|
|
2022
Q1 | $1.37M | Sell |
84,000
-37,900
| -31% | -$594K | ﹤0.01% | 5469 |
|
|
2021
Q4 | $1.99M | Sell |
121,900
-19,300
| -14% | -$325K | ﹤0.01% | 4506 |
|
|
2021
Q3 | $2.1M | Buy |
141,200
+69,200
| +96% | +$1.11M | ﹤0.01% | 4380 |
|
|
2021
Q2 | $1.44M | Buy |
72,000
+48,000
| +200% | +$952K | ﹤0.01% | 5021 |
|
|
2021
Q1 | $554K | Sell |
24,000
-65,300
| -73% | -$1.82M | ﹤0.01% | 6609 |
|
|
2020
Q4 | $2.21M | Buy |
89,300
+26,700
| +43% | +$885K | ﹤0.01% | 3310 |
|
|
2020
Q3 | $2.6M | Sell |
62,600
-100,800
| -62% | -$4.63M | ﹤0.01% | 2646 |
|
|
2020
Q2 | $7.83M | Buy |
163,400
+146,400
| +861% | +$11.3M | 0.01% | 1368 |
|
|
2020
Q1 | $1.07M | Sell |
17,000
-66,200
| -80% | -$5.95M | ﹤0.01% | 2722 |
|
|
2019
Q4 | $10.3M | Buy |
+83,200
| New | +$7.45M | 0.01% | 627 |
|
|
2019
Q3 | – | Sell |
-2,900
| Closed | -$231K | – | 5940 |
|
|
2019
Q2 | $231K | Sell |
2,900
-10,100
| -78% | -$904K | ﹤0.01% | 4540 |
|
|
2019
Q1 | $1.45M | Buy |
+13,000
| New | +$1.42M | ﹤0.01% | 2369 |
|
|
2018
Q4 | – | Sell |
-8,000
| Closed | -$1.01M | – | 5937 |
|
|
2018
Q3 | $1.01M | Sell |
8,000
-4,900
| -38% | -$519K | ﹤0.01% | 2741 |
|
|
2018
Q2 | $1.08M | Buy |
12,900
+4,800
| +59% | +$351K | ﹤0.01% | 2654 |
|
|
2018
Q1 | $498K | Sell |
8,100
-6,200
| -43% | -$374K | ﹤0.01% | 3483 |
|
|
2017
Q4 | $835K | Buy |
14,300
+400
| +3% | +$25.2K | ﹤0.01% | 2566 |
|
|
2017
Q3 | $807K | Buy |
13,900
+11,800
| +562% | +$1.27M | ﹤0.01% | 2525 |
|
|
2017
Q2 | $254K | Buy |
+2,100
| New | +$243K | ﹤0.01% | 3775 |
|
|
2017
Q1 | – | Sell |
-4,500
| Closed | -$489K | – | 4817 |
|
|
2016
Q4 | $489K | Buy |
4,500
+2,500
| +125% | +$298K | ﹤0.01% | 2879 |
|
|
2016
Q3 | $329K | Hold |
2,000
| – | – | ﹤0.01% | 3213 |
|
|
2016
Q2 | $285K | Sell |
2,000
-3,900
| -66% | -$569K | ﹤0.01% | 3384 |
|
|
2016
Q1 | $758K | Buy |
+5,900
| New | +$697K | ﹤0.01% | 2130 |
|
|
2015
Q3 | – | Sell |
-1,300
| Closed | -$314K | – | 4302 |
|
|
2015
Q2 | $314K | Sell |
1,300
-10,000
| -88% | -$2.66M | ﹤0.01% | 2779 |
|
|
2015
Q1 | $3.19M | Buy |
+11,300
| New | +$2.45M | 0.02% | 597 |
|
Jane Street's ICPT Position: Q4 2023 in Review
Jane Street sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 14,201 shares — an estimated $263K sold.
Jane Street first reported a position in ICPT in Q4 2013 and held it in 29 quarters. The position peaked at $5.8M in Q1 2015. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- Jane Street reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- Jane Street sold 14,201 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $263K.
- Jane Street first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2013 and held it in 29 quarters.
- Jane Street's Intercept Pharmaceuticals, Inc. position peaked at $5.8M in Q1 2015.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.